SBC Medical Group Holdings (SBCWW) EBIT Margin (2023 - 2025)
Historic EBIT Margin for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to 36.63%.
- SBC Medical Group Holdings' EBIT Margin rose 105700.0% to 36.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.26%, marking a year-over-year decrease of 68500.0%. This contributed to the annual value of 34.23% for FY2024, which is 22800.0% down from last year.
- Latest data reveals that SBC Medical Group Holdings reported EBIT Margin of 36.63% as of Q3 2025, which was up 105700.0% from 33.57% recorded in Q2 2025.
- In the past 5 years, SBC Medical Group Holdings' EBIT Margin registered a high of 51.39% during Q2 2024, and its lowest value of 10.62% during Q4 2024.
- Over the past 3 years, SBC Medical Group Holdings' median EBIT Margin value was 38.48% (recorded in 2023), while the average stood at 37.21%.
- Per our database at Business Quant, SBC Medical Group Holdings' EBIT Margin crashed by -278500bps in 2024 and then soared by 105700bps in 2025.
- SBC Medical Group Holdings' EBIT Margin (Quarter) stood at 38.48% in 2023, then crashed by -72bps to 10.62% in 2024, then skyrocketed by 245bps to 36.63% in 2025.
- Its EBIT Margin stands at 36.63% for Q3 2025, versus 33.57% for Q2 2025 and 51.14% for Q1 2025.